DURECT CorporationAbout DURECTProductsBusiness DevelopmentScience & TechnologiesInvestor RelationsCareersNews
DURECT: Developing products to treat chronic  debilitating disease and technologies that enable biotechnology products.
DURECT Featured Clinical ProductsLatest News

ELADUR

Indication:

Focus:

Post-Herpetic Neuralgia

ELADUR™
Is a sustained release formulation of bupivacaine using our TRANSDUR® technology to provide pain relief for patients suffering from Post-Herpetic Neuralgia (post-shingles pain or PHN).

Learn more
View complete product pipeline

  © 2000-2014 DURECT Corporation
  Last updated: September 20, 2012
  built@zoomedia.com
Search     Contact     Site Index     Legal Notice     Privacy Policy